ARS Pharmaceuticals Statistics
Total Valuation
SPRY has a market cap or net worth of $1.06 billion. The enterprise value is $840.50 million.
| Market Cap | 1.06B |
| Enterprise Value | 840.50M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, after market close.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SPRY has 96.90 million shares outstanding. The number of shares has increased by 2.40% in one year.
| Shares Outstanding | 96.90M |
| Shares Change (YoY) | +2.40% |
| Shares Change (QoQ) | +0.37% |
| Owned by Insiders (%) | 23.47% |
| Owned by Institutions (%) | 62.61% |
| Float | 43.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 106,391.04 |
| Forward PS | 114.62 |
| PB Ratio | 4.75 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 84,049.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 60.90, with a Debt / Equity ratio of 0.00.
| Current Ratio | 60.90 |
| Quick Ratio | n/a |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -21.10% and return on invested capital (ROIC) is -27.67%.
| Return on Equity (ROE) | -21.10% |
| Return on Assets (ROA) | -20.50% |
| Return on Capital (ROIC) | -27.67% |
| Revenue Per Employee | $385 |
| Profits Per Employee | -$1.91M |
| Employee Count | 26 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +56.86% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +56.86% |
| 50-Day Moving Average | 9.33 |
| 200-Day Moving Average | 7.31 |
| Relative Strength Index (RSI) | 60.91 |
| Average Volume (20 Days) | 908,765 |
Short Selling Information
The latest short interest is 8.74 million, so 9.02% of the outstanding shares have been sold short.
| Short Interest | 8.74M |
| Short Previous Month | 6.88M |
| Short % of Shares Out | 9.02% |
| Short % of Float | 20.26% |
| Short Ratio (days to cover) | 9.94 |
Income Statement
In the last 12 months, SPRY had revenue of $10,000 and -$49.70 million in losses. Loss per share was -$0.52.
| Revenue | 10,000 |
| Gross Profit | 10,000 |
| Operating Income | -62.00M |
| Pretax Income | -49.70M |
| Net Income | -49.70M |
| EBITDA | -49.63M |
| EBIT | -49.70M |
| Loss Per Share | -$0.52 |
Balance Sheet
The company has $223.63 million in cash and $217,000 in debt, giving a net cash position of $223.42 million or $2.31 per share.
| Cash & Cash Equivalents | 223.63M |
| Total Debt | 217,000 |
| Net Cash | 223.42M |
| Net Cash Per Share | $2.31 |
| Equity (Book Value) | 223.87M |
| Book Value Per Share | 2.31 |
| Working Capital | 222.53M |
Cash Flow
In the last 12 months, operating cash flow was -$53.55 million and capital expenditures -$65,000, giving a free cash flow of -$53.61 million.
| Operating Cash Flow | -53.55M |
| Capital Expenditures | -65,000 |
| Free Cash Flow | -53.61M |
| FCF Per Share | -$0.56 |
Margins
Gross margin is 100.00%, with operating and profit margins of -619,990.00% and -496,960.00%.
| Gross Margin | 100.00% |
| Operating Margin | -619,990.00% |
| Pretax Margin | -496,960.00% |
| Profit Margin | -496,960.00% |
| EBITDA Margin | -496,320.00% |
| EBIT Margin | -496,960.00% |
| FCF Margin | -536,120.00% |
Dividends & Yields
SPRY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.40% |
| Shareholder Yield | -2.40% |
| Earnings Yield | -4.67% |
| FCF Yield | -5.04% |
Analyst Forecast
The average price target for SPRY is $18.33, which is 66.94% higher than the current price. The consensus rating is "Buy".
| Price Target | $18.33 |
| Price Target Difference | 66.94% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 617.42% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SPRY has an Altman Z-Score of 171.41 and a Piotroski F-Score of 1.
| Altman Z-Score | 171.41 |
| Piotroski F-Score | 1 |